Skip to main content
. 2020 Jun 11;154(2):266–276. doi: 10.1093/ajcp/aqaa044

Figure 1.

Figure 1

A, Example of an in-house polymerase chain reaction–based workflow for RAS biomarker testing. Times for the various assay steps are averages or ranges. The Idylla impact on workflow is shown in brackets. B, Example of an in-house next-generation sequencing (NGS)–based workflow for RAS biomarker testing. Times for the various assay steps are averages or ranges. The Idylla impact on workflow is shown in brackets. C, Example of a send-out NGS-based workflow for RAS biomarker testing. Times for the various assay steps are averages or ranges. The Idylla impact on workflow is shown in brackets. EMR, electronic medical record; FFPE, formalin fixed, paraffin embedded.